Search Results

NSC 348884 5mg  | ≥99%

CSNpharm

NSC348884 is a nucleophosmin (NPM) inhibitor, inhibits cell proliferation and induce apoptosis in various cancer cell lines with IC50 values ranging from 1.4-4 µM.

More Information Supplier Page

NSC 348884 1mg  | ≥99%

CSNpharm

NSC348884 is a nucleophosmin (NPM) inhibitor, inhibits cell proliferation and induce apoptosis in various cancer cell lines with IC50 values ranging from 1.4-4 µM.

More Information Supplier Page

NSC 348884 100mg  | ≥99%

CSNpharm

NSC348884 is a nucleophosmin (NPM) inhibitor, inhibits cell proliferation and induce apoptosis in various cancer cell lines with IC50 values ranging from 1.4-4 µM.

More Information Supplier Page

NSC 348884 50mg  | ≥99%

CSNpharm

NSC348884 is a nucleophosmin (NPM) inhibitor, inhibits cell proliferation and induce apoptosis in various cancer cell lines with IC50 values ranging from 1.4-4 µM.

More Information Supplier Page

Tipiracil HCl 25mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page

Tipiracil HCl 5mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page

Tipiracil HCl 100mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page

Tipiracil HCl 10mg  | ≥99%

CSNpharm

Tipiracil HCl is an inhibitor of thymidine phosphorylase (TPase) with IC50 of 35 nM. It has been used in the combination therapy of metastatic colorectal cancer.

More Information Supplier Page